40 Patient-reported outcomes from the CodeBreaK 200 phase III trial comparing sotorasib versus docetaxel in KRAS G12C-mutated NSCLC
D.M. Waterhouse, S. Rothschild, C. Dooms, B. Mennecier et autres
us, ch, be, fr, de, es, nl, gr, kr, au, jp, ca, br, dk, pl, gb, it (code pays fourni par la source)